tumor lysate pulsed dendritic cell immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for tumor lysate pulsed dendritic cell immunotherapy, covering 2019-05-03 to 2019-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors [Phase 2]